338 filings
Page 10 of 17
8-K
ax7s 1r41
4 May 17
Other Events
12:00am
8-K
bxyyav
28 Apr 17
Sorrento Therapeutics Announces Closing of its Acquisition of Virttu Biologics
12:00am
8-K
m6nzrae8obx9s
19 Apr 17
Sorrento Announces Closing of Public Offering of Common Stock
12:00am
8-K
l7uib350
13 Apr 17
Sorrento Announces Pricing of Public Offering of Common Stock
12:00am
8-K
qmcdro
24 Mar 17
Entry into a Material Definitive Agreement
12:00am
8-K
0fife6ab9i
21 Mar 17
Entry into a Material Definitive Agreement
12:00am
8-K
628akfx
20 Mar 17
Sorrento and Wildcat Announce Resolution
12:00am
8-K/A
w88blg6bnrq6s8
20 Jan 17
Financial Statements and Exhibits
12:00am
8-K
wuca7xcg ll7wyukg8
5 Jan 17
Termination of a Material Definitive Agreement
12:00am
8-K
xnp aq9yz2
29 Nov 16
Sorrento Therapeutics, Inc. Secures $75 Million Loan Facility
12:00am
8-K
l4ku5yt0gtb bs
16 Nov 16
Sorrento’s TNK Therapeutics Subsidiary to Acquire Virttu Biologics
12:00am
8-K
cohztg34bk9b
8 Nov 16
Sorrento Therapeutics Closes Acquisition of Scilex
12:00am
8-K
7epn1h78x2c 74ny0ckx
1 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
9jrdnxbcw gwwqm
22 Sep 16
Regulation FD Disclosure
12:00am
8-K
2k16lvf r2e8z
13 Sep 16
Sorrento Appoints Miranda Toledano As Executive Vice President of Corporate Development, and President of LA Cell
12:00am
8-K
frlocec 1lg6q3zcnt8c
7 Sep 16
Changes in Registrant's Certifying Accountant
12:00am
8-K
bjidgbz
17 Aug 16
Entry into a Material Definitive Agreement
12:00am
8-K
76k7gz inrv
15 Aug 16
Other Events
12:00am
8-K
60e6rcm3vq98
8 Aug 16
Entry into a Material Definitive Agreement
12:00am
8-K
adu3ag950o
1 Aug 16
Departure of Directors or Certain Officers
12:00am